Cian Healthcare Stock Forecast for 2023 - 2025 - 2030
Updated on 05/02/2024
Cian Healthcare Fair Value Forecast for 2023 - 2025 - 2030
Cian Healthcare's Price has seen impressive growth In the last year, rising from 0.00 to 0.00 – a growth of 100.00%. In the next year, analysts believe that Fair Value will reach 0.00 – an increase of 100.00%. For the next five years, the forecast is for Fair Value to grow by 100.00%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| SUNPHARMA Stock Forecast | Sun Pharmaceutical Industries | Outperform |
8
|
Rp1.50k | Buy/Sell | Rp1.52k | 5.52% |
| CIPLA Stock Forecast | Cipla | Outperform |
18
|
Rp1.40k | Buy/Sell | Rp1.43k | 7.04% |
| 500124 Stock Forecast | Dr. Reddy's Laboratories | Hold |
18
|
Rp6.21k | Buy/Sell | Rp5.67k | -2.50% |
| ZYDUSLIFE Stock Forecast | Zydus Lifesciences | Outperform |
18
|
Rp953.55 | Buy/Sell | Rp655.25 | -9.02% |
| 500420 Stock Forecast | Torrent Pharmaceuticals | Outperform |
18
|
Rp2.64k | Buy/Sell | Rp2.13k | 6.04% |
Cian Healthcare Revenue Forecast for 2023 - 2025 - 2030
Cian Healthcare's Revenue has seen impressive growth In the last two years, rising from 573.29M to 686.97M – a growth of 19.83%. The next year, 0 experts forecast that Cian Healthcare's Revenue will decrease by 2.40%, reaching 670.46M. In 2030, professionals predict that Cian Healthcare's Revenue will decrease by 2.77%, reaching 667.91M.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| 500257 Stock Forecast | Lupin | Hold |
12
|
Rp1.65k | Buy/Sell | Rp1.11k | -5.80% |
| AUROPHARMA Stock Forecast | Aurobindo Pharma | Outperform |
18
|
Rp1.15k | Buy/Sell | Rp1.09k | 1.95% |
| 500488 Stock Forecast | Abbott India | Outperform |
18
|
Rp26.42k | Buy/Sell | Rp24.75k | 11.68% |
.jpg)
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| 500660 Stock Forecast | GlaxoSmithKline Pharmaceutical... | Hold |
18
|
Rp2.09k | Buy/Sell | Rp1.78k | 1.10% |
| IPCALAB Stock Forecast | Ipca Laboratories | Hold |
18
|
Rp1.34k | Buy/Sell | Rp987.00 | -14.41% |
| GLENMARK Stock Forecast | Glenmark Pharmaceuticals | Outperform |
18
|
Rp1.06k | Buy/Sell | Rp767.80 | -14.44% |
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| 506943 Stock Forecast | J. B. Chemicals & Pharmaceutic... | Outperform |
18
|
Rp1.90k | Buy/Sell | Rp1.89k | 1.99% |
| AJANTPHARM Stock Forecast | Ajanta Pharma | Outperform |
18
|
Rp2.22k | Buy/Sell | Rp1.95k | 6.30% |
| 500302 Stock Forecast | Piramal Enterprises | Hold |
18
|
Rp924.90 | Buy/Sell | Rp1.11k | 8.12% |
Cian Healthcare EBITDA Forecast for 2023 - 2025 - 2030
In the last two years, Cian Healthcare's EBITDA has seen an increase, rising from 75.19M to 130.97M. This represents a growth of 74.19%. According to 0 prominent analysts, Cian Healthcare's EBITDA will fall by 17.36% in the next year, reaching 108.23M. By 2030, professionals believe that Cian Healthcare's EBITDA will decrease by 17.41%, reaching 108.17M – a concerning trend for the company.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| APLLTD Stock Forecast | Alembic Pharmaceuticals | Hold |
16
|
Rp999.60 | Buy/Sell | Rp742.44 | -8.46% |
| PFIZER Stock Forecast | Pfizer | Outperform |
18
|
Rp4.26k | Buy/Sell | Rp4.53k | 15.92% |
| 500674 Stock Forecast | Sanofi India | Outperform |
18
|
Rp8.32k | Buy/Sell | Rp8.61k | 10.16% |
Cian Healthcare EBIT Forecast for 2023 - 2025 - 2030
Cian Healthcare's EBIT has seen growth In the last two years, going from 30.70M to 76.66M – a gain of 149.71% In the following year, 0 experts forecast Cian Healthcare's EBIT will decrease by 12.24%, to 67.28M. In 2030, professionals predict that Cian Healthcare's EBIT will decrease by 13.04%, to 66.66M.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| NATCOPHARM Stock Forecast | NATCO Pharma | Outperform |
16
|
Rp1.02k | Buy/Sell | Rp822.45 | -1.29% |
| 506820 Stock Forecast | AstraZeneca Pharma India | - |
18
|
Rp5.34k | Buy/Sell | Rp0.00 | -100.00% |
| 524742 Stock Forecast | Caplin Point Laboratories | Buy |
17
|
Rp1.36k | Buy/Sell | Rp1.47k | 13.78% |
Cian Healthcare EPS Price Prediction Forecast for 2023 - 2025 - 2030
Cian Healthcare's EPS has seen impressive growth In the last year, rising from 0.00 to 0.00 – a growth of 100.00%. In the next year, analysts believe that EPS will reach 0.00 – an increase of 100.00%. For the next five years, the forecast is for EPS to grow by 100.00%.
| Ticker | Name | Consensus | Stock Rating | Price | Buy/Sell | Price Target | Upside/Downside |
|---|---|---|---|---|---|---|---|
| 532482 Stock Forecast | Granules India | Buy |
18
|
Rp422.85 | Buy/Sell | Rp381.00 | 13.52% |
| STAR Stock Forecast | Strides Pharma Science | Outperform |
9
|
Rp896.05 | Buy/Sell | Rp618.00 | -8.10% |
| 500126 Stock Forecast | Procter & Gamble Health | - |
17
|
Rp4.92k | Buy/Sell | Rp5.62k | -100.00% |
.jpg)